Joachim Trier goes deep into the silent ending of his Oscar contender, breaking down how he constructed a script that built toward such a powerful moment. “I’m out on a limb with this one,” said Trier ...
When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...
IT: Welcome to Derry Episode 5 ends with a development that should send chills down any hardcore Stephen King fan’s spine. It’s not enough that our heroes finally visited the house on Neibolt Street ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
SPOILER ALERT: This story contains spoilers for the first two episodes of “Pluribus,” streaming now on Apple TV. Not only did “Breaking Bad” earn four more seasons that cemented it as one of the ...
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results